Dharam V. Ablashi

10.3k total citations · 1 hit paper
142 papers, 6.4k citations indexed

About

Dharam V. Ablashi is a scholar working on Epidemiology, Oncology and Infectious Diseases. According to data from OpenAlex, Dharam V. Ablashi has authored 142 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Epidemiology, 86 papers in Oncology and 33 papers in Infectious Diseases. Recurrent topics in Dharam V. Ablashi's work include Cytomegalovirus and herpesvirus research (93 papers), Viral-associated cancers and disorders (82 papers) and Herpesvirus Infections and Treatments (65 papers). Dharam V. Ablashi is often cited by papers focused on Cytomegalovirus and herpesvirus research (93 papers), Viral-associated cancers and disorders (82 papers) and Herpesvirus Infections and Treatments (65 papers). Dharam V. Ablashi collaborates with scholars based in United States, Germany and Canada. Dharam V. Ablashi's co-authors include S. Zaki Salahuddin, Flossie Wong‐Staal, Steven F. Josephs, Robert C. Gallo, Phillip D. Markham, Mark H. Kaplan, Peter Biberfeld, Richard L. Gallo, Louise G. Chatlynne and James E. Whitman and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Dharam V. Ablashi

140 papers receiving 6.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Isolation of a New Virus, HBLV, in Patients with Lymphoproliferative Disorders

1986 1.1k citations S. Zaki Salahuddin, Dharam V. Ablashi et al. profile →

Peers

Dharam V. Ablashi

EPIDE

ONCOL

ID

IMMUN

PMH

Gary R. Pearson United States

S. Zaki Salahuddin United States

Craig E. Metroka United States

Sheila C. Dollard United States

Donald R. Carrigan United States

Marjaleena Koskiniemi Finland

Xavier Álvarez United States

Randall J. Cohrs United States

Don Gilden United States

James C. Niederman United States

Gary R. Pearson United States

Dharam V. Ablashi

2.4k ×0.5

EPIDE

3.4k ×1.0

ONCOL

1.6k ×0.9

ID

1.3k ×2.1

IMMUN

236 ×0.4

PMH

Citations per year, relative to Dharam V. Ablashi Dharam V. Ablashi (= 1×) peers Gary R. Pearson

Countries citing papers authored by Dharam V. Ablashi

Since Specialization

Citations

This map shows the geographic impact of Dharam V. Ablashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dharam V. Ablashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dharam V. Ablashi more than expected).

Fields of papers citing papers by Dharam V. Ablashi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dharam V. Ablashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dharam V. Ablashi. The network helps show where Dharam V. Ablashi may publish in the future.

Co-authorship network of co-authors of Dharam V. Ablashi

This figure shows the co-authorship network connecting the top 25 collaborators of Dharam V. Ablashi. A scholar is included among the top collaborators of Dharam V. Ablashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dharam V. Ablashi. Dharam V. Ablashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Hídvégi, Máté, et al.. (2023). The effects of Avemar treatment on feline immunodeficiency virus infected cell cultures. Veterinary Medicine and Science. 9(4). 1446–1455. 2 indexed citations

2.

Viza, D., et al.. (2020). Transfer Factor as an Option for Managing the COVID-19 Pandemic. Folia Biologica. 66(3). 86–90. 3 indexed citations

3.

Greninger, Alexander L., Pavitra Roychoudhury, Negar Makhsous, et al.. (2018). Copy Number Heterogeneity, Large Origin Tandem Repeats, and Interspecies Recombination in Human Herpesvirus 6A (HHV-6A) and HHV-6B Reference Strains. Journal of Virology. 92(10). 18 indexed citations

4.

Gulve, Nitish, et al.. (2016). Anti-herpesviral effects of a novel broad range anti-microbial quaternary ammonium silane, K21. Antiviral Research. 131. 166–173. 16 indexed citations

5.

Ablashi, Dharam V.. (2015). The Antimicrobial Compound, K21, Inhibits Replication of Enveloped and Non-Enveloped DNA and RNA Viruses. Journal of Antivirals & Antiretrovirals. 1 indexed citations

6.

Arbuckle, Jesse H., Shara N. Pantry, Maria M. Medveczky, et al.. (2013). Mapping the telomere integrated genome of human herpesvirus 6A and 6B. Virology. 442(1). 3–11. 50 indexed citations

7.

Loginov, Raisa, et al.. (2010). Quantitative HHV-6B antigenemia test for the monitoring of transplant patients. European Journal of Clinical Microbiology & Infectious Diseases. 29(7). 881–886. 9 indexed citations

8.

Yao, Karen, John R. Crawford, Anthony L. Komaroff, Dharam V. Ablashi, & Steven Jacobson. (2010). Review part 2: Human herpesvirus‐6 in central nervous system diseases. Journal of Medical Virology. 82(10). 1669–1678. 71 indexed citations

9.

Tai, Albert, János Luka, Dharam V. Ablashi, & Brigitte T. Huber. (2009). HHV-6A infection induces expression of HERV-K18-encoded superantigen. Journal of Clinical Virology. 46(1). 47–48. 62 indexed citations

10.

Pellett, Philip E., Deborah Wright, Eric A. Engels, et al.. (2003). Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donors. Transfusion. 43(9). 1260–1268. 110 indexed citations

11.

Klußmann, Jens Peter, Andreas Müller, Mathias Wagner, et al.. (2000). Human herpesvirus type 8 in salivary gland tumors. Journal of Clinical Virology. 16(3). 239–246. 22 indexed citations

12.

Strickler, Howard D., James J. Goedert, Florian Bethke, et al.. (1999). Human Herpesvirus 8 Cellular Immune Responses in Homosexual Men. The Journal of Infectious Diseases. 180(5). 1682–1685. 26 indexed citations

13.

Ablashi, Dharam V., et al.. (1998). HHV-6 Infection in HIV-Infected Asymptomatic and AIDS Patients. Intervirology. 41(1). 1–9. 22 indexed citations

14.

Qavi, Hamida, et al.. (1996). Morphological and ultrastructural changes induced in corneal epithelial cells by HIV-1 and HHV-6 in vitro. Current Eye Research. 15(6). 597–604. 9 indexed citations

15.

Ablashi, Dharam V.. (1994). Summary: Viral Studies of Chronic Fatigue Syndrome. Clinical Infectious Diseases. 18(Supplement_1). S130–S133. 30 indexed citations

16.

Suhadolnik, Robert J., et al.. (1993). RNA Drug Therapy Acting via the 2–5A Synthetase/RNase L Pathway. Annals of the New York Academy of Sciences. 685(1). 756–757. 1 indexed citations

17.

Salahuddin, Syed Zaki, et al.. (1993). Human herpes virus-6 (HHV-6) in diseases. Clinical and Diagnostic Virology. 1(2). 81–100. 9 indexed citations

18.

Yadav, M, et al.. (1991). Antibody reactivity with two strains of human herpesvirus‐6 in Malaysians. Journal of Medical Virology. 33(4). 236–239. 7 indexed citations

19.

Lusso, Paolo, Barbara Ensoli, Phillip D. Markham, et al.. (1989). Productive dual infection of human CD4+ T lymphocytes by HIV-1 and HHV-6. Nature. 337(6205). 370–373. 245 indexed citations

20.

Ablashi, Dharam V., Paolo Lusso, Chia‐Ling Hung, et al.. (1988). Utilization of human hematopoietic cell lines for the propagation and characterization of HBLV (human herpesvirus 6). International Journal of Cancer. 42(5). 787–791. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact